(Press-News.org) A drug which targets a key gene fault could halt an aggressive womb cancer and shrink tumours, according to research published in the British Journal of Cancer*.
The scientists, from the Division of Gynaecologic Oncology at Yale School of Medicine funded by the National Institutes of Health, showed that the drug afatinib not only killed off uterine serous cancer cells after stopping their growth but also caused tumours to shrink.
The drug, a type of personalised medicine, attacks faults in the HER2 gene which lie at the heart of the cancer cells. This stops the disease in its tracks. Drugs which target HER2 are already used to treat breast cancer.
Uterine serous carcinoma is a fast-growing type of womb cancer. It is more likely than other womb cancers to come back after treatment, returning in one in two patients* even if it is caught early.
Although the cancer causes less than one in 10 womb cancers**, it accounts for 40 per cent of all deaths from womb cancer* – which is around 800 deaths every year in the UK***.
The researchers looked at uterine serous carcinoma cell lines with normal and increased levels of the HER2 protein to see how afatinib affected the cancer. They found that the drug had a big impact on cancer cells with this gene fault, and could stop them growing and kill them. They also found that the drug shrank the size of uterine serous tumours when given to mice.
Afatinib works by targeting receptors that respond to growth signals. Cancers with high levels of the HER2 protein have too many of these receptors, allowing them to grow out of control. The drug is an example of personalised or tailored treatment, which works by specifically targeting the faulty genes and molecules in an individual's cancer. Afatinib is being tested in clinical trials for a number of cancers including bowel cancer and certain types of lung and breast cancer.
Lead author, Dr Carlton Schwab from the Division of Gynaecologic Oncology at the Yale School of Medicine, said: "Our research uses the vast amount of genetic information now available to find ways to shake the foundations of cancer and stop the disease progressing.
"We have shown similar results to early data of afatinib in non small cell lung cancer, which ultimately led to clinical trials and a shift in the way some of these cancers are treated. There could be real possibilities to make a difference for patients, and this study has laid the foundations for the development of clinical trials testing the drug in women whose cancers have this HER2 gene fault and don't respond to chemotherapy."
Nell Barrie, senior science information manager at Cancer Research UK, said: "Targeted treatments like afatinib offer an opportunity to home in on the faults at the heart of each cancer. The findings of this research still need to be proven in people, but this research suggests that afatinib could be an effective treatment in treating this rare but aggressive type of cancer.
"Cancer Research UK has invested heavily in the research and infrastructure to help deliver more personalised treatments for cancer and continues to do so. We believe that personalised approaches will one day enable doctors to treat people based on the genetic fingerprint of their tumour."
INFORMATION:
For media enquiries contact Emily Head on 020 3469 6189 or, out of hours, on 07050 264 059.
Notes to editor:
* Schwab et al. Afatinib demonstrates remarkable activity against HER2 amplified uterine serous endometrial cancer in vitro and in vivo. British Journal of Cancer. DOI: 10.1038/bjc.2014.519
** http://www.cancerresearchuk.org/about-cancer/type/womb-cancer/about/types-of-womb-cancer#pap
*** Estimate based on 40% of womb cancer deaths being caused by uterine serous carcinoma (Schwab et al. 2014) and applied to the number of women who died from womb cancer (ICD-10 C54-C55) in the UK in 2012.
Targeted treatment could halt womb cancer growth
2014-10-01
ELSE PRESS RELEASES FROM THIS DATE:
Third of countries struggling to meet the needs of aging population
2014-10-01
People around the world are living longer, but social policies to support their wellbeing in later life are lagging behind in many countries. This is according a new report by HelpAge International, developed in partnership with the University of Southampton.
More than a third of countries are falling significantly behind those at the top of the Global AgeWatch Index. It ranks 96 nations on the basis of the quality of life and social and economic wellbeing of older people (over 60s). The Index can also help governments to identify policies and institutional contexts that ...
Developing countries should enroll medical and nursing students from rural areas
2014-10-01
Nearly one third of medical and nursing students in developing countries may have no intention of working in their own countries after graduation, while less than one fifth of them intend to work in rural areas where they are needed most, according to a new study.
Health workforce shortages have been a major factor driving the current outbreak of Ebola in western Africa. The disease initially spread rapidly in rural parts of three of the world's poorest countries (Guinea, Sierra Leone and Liberia), where health workers are scarcest.
The study, which was published in ...
Minimum alcohol pricing would be up to 50 times more effective than below cost selling ban
2014-10-01
The previous policy of setting a minimum unit price would have had a 40-50 times greater effect, particularly among harmful drinkers, say researchers.
Increasing the price of alcohol has been shown to be effective in reducing both consumption levels and harms, and the UK government has been considering different policy options for price regulation in England and Wales.
In 2010, the government announced a ban on "below cost selling" to target drinks which are currently sold so cheaply that their price is below the cost of the tax (duty and VAT) payable on the product. ...
Healthy lifestyle could prevent nearly half of all diabetic pregnancies
2014-10-01
Gestational diabetes is a common pregnancy complication that has long-term adverse health implications for both mothers and babies.
Several modifiable risk factors before pregnancy have been identified over the past decade. These include maintaining a healthy weight, consuming a healthy diet, regular physical activity, and not smoking.
So a team of researchers based in the United States set out to examine the effect of these "low risk" lifestyle factors on the risk of gestational diabetes – and measure the portion of the condition that may be preventable through adhering ...
The Lancet: Latest estimates show that preterm birth complications and pneumonia are the leading causes of death in children under 5 years
2014-10-01
Complications from preterm (premature) births and pneumonia are now the leading causes of death in children under five years, together responsible for nearly 2 million deaths in 2013, according to the latest estimates, published today [Tuesday 30 September] in The Lancet.
Researchers led by Professor Robert Black, of Johns Hopkins Bloomberg School of Public Health, Baltimore, USA, used the latest available data and modelling methods to examine what caused an estimated 6•3 million deaths of newborn babies (neonates) and children under five years in 2013.
They found that ...
The Lancet Diabetes & Endocrinology: Genetic study casts further doubt that vitamin D prevents the development of type 2 diabetes
2014-10-01
A large genetic study, published today in The Lancet Diabetes & Endocrinology journal, has concluded there is no evidence of a causal link between a person's vitamin D levels [1], and whether they develop type 2 diabetes.
The findings of the study, conducted by scientists at the University of Cambridge, challenge evidence from earlier observational studies which suggest that higher concentrations of circulating vitamin D might prevent type 2 diabetes. This evidence led to speculation that the development of type 2 diabetes is associated with vitamin D insufficiency. ...
Improving babies' language skills before they're even old enough to speak
2014-10-01
In the first months of life, when babies begin to distinguish sounds that make up language from all the other sounds in the world, they can be trained to more effectively recognize which sounds "might" be language, accelerating the development of the brain maps which are critical to language acquisition and processing, according to new Rutgers research.
The study by April Benasich and colleagues of Rutgers University-Newark is published in the October 1 issue of the Journal of Neuroscience. The researchers found that when 4-month-old babies learned to pay attention to ...
New genetic 'operating system' facilitated evolution of 'bilateral' animals
2014-10-01
The evolution of worms, insects, vertebrates and other "bilateral" animals—those with distinct left and right sides—from less complex creatures like jellyfish and sea anemones with "radial" symmetry may have been facilitated by the emergence of a completely new "operating system" for controlling genetic instructions in the cell.
That's the hypothesis of molecular biologists at UC San Diego. They report in the October 1 issue of the journal Genes & Development that this new system of controlling gene networks, analogous to a new computer operating system, paved the way ...
First comprehensive meshfree numerical simulation of skeletal muscle tissue achieved
2014-10-01
Engineers at the University of California, San Diego, have completed the first comprehensive numerical simulation of skeletal muscle tissue using a method that uses the pixels in an image as data points for the computer simulation—a method known as mesh-free simulation.
The researchers, led by J.S. Chen, the William Prager Professor of structural engineering at the Jacobs School of Engineering at UC San Diego, presented their findings on the development of this method at the CompIMAGE'14 conference in Pittsburgh this month. Chen also gave a keynote speech about the work. ...
Low social support linked to poor health in young heart attack survivors
2014-09-30
Having few friends, family and a general lack of social support is associated with poor health and quality of life and depression in young men and women a year after having a heart attack, according to new research in the Journal of the American Heart Association.
Social support is the perception of having friends or family who serve as confidants and companions, offer advice and information, show emotional concern, or provide financial or material support, said Emily Bucholz, lead researcher and a student in the School of Medicine and the Department of Chronic Disease ...